Gary S. Jacob
CHIEF DEVELOPMENT OFFICER, Director · OKYO Pharma Ltd
- 2026
- Aug 7, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Gary S. Jacob files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Gabriele M. Cerrone - $35K in OKYO purchases and sales in the last 12 months
- Flavio Mantelli - $28K in OKYO purchases and sales in the last 12 months
- Robert John Dempsey - $23K in OKYO purchases and sales in the last 12 months
- John P. Brancaccio - $7K in OKYO purchases and sales in the last 12 months
- Rajkumar V. Patil - $5K in OKYO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Gary S. Jacob?
Gary S. Jacob is a corporate insider, tracked as CHIEF DEVELOPMENT OFFICER, Director of OKYO Pharma Ltd (OKYO). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Gary S. Jacob submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Gary S. Jacob been buying or selling stock?
Recorded transactions: 1 open-market purchase ($5K) and 0 open-market sales across all tracked filings.
